Product
Core Treatment Placebo
1 clinical trial
1 indication
Indication
Atopic DermatitisClinical trial
A Randomized, Double Blind and Placebo Controlled Phase 3 Study to Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic DermatitisStatus: Completed, Estimated PCD: 2022-08-12